Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease 2024-11-22
  2. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals 2023-04-01
  3. CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design 2022-02-28

Studies

4 studies carry this tag.

Date range

2002 to 2024

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Acta neuropathologica 1
  • Brain : a journal of neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 74 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024-11-22 Biomarkers

    PTau217R reliably predicts regional tau accumulation in early AD, reducing reliance on tau PET scans and broadening its clinical application.

  2. Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Brain : a journal of neurology 2023-04-01 Biomarkers

    The A+P+T- group showed a slower rate of increase in tau-PET compared to the A+P+T+ group, primarily in neocortical regions.

  3. CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design

    ✓ Peer-reviewed alzhub usefulness score 52 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-02-28 Biomarkers

    Clinical trials testing tau-targeting therapies may benefit from using fluid biomarkers to recruit individuals at risk of tau aggregation.

  4. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Acta neuropathologica 2002-05-30 Biomarkers

    Tau-immunoreactive astrocytes in progressive supranuclear palsy (PSP) have a distinctive morphology and are referred to as tufted astrocytes (TA).

All topic tags with their study counts